STAT+: The crumbling employer-based health insurance system

You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and policy of health and medicine. Sign up here to receive it in your inbox on Tuesdays and Thursdays.

Cody Rhodes, a WWE star and friend of the trans community; and Triple H, former pro wrestler and son-in-law of Education Department Secretary Linda McMahon, helped kick off the return of the presidential fitness test. Send news tips and your favorite wrestling moves to John.Wilkerson@statnews.com or John_Wilkerson.07 on Signal.

U.S. workers and businesses are getting soaked

Today, Bob Herman launched a series on the crumbling employer-based health insurance system. He wrote about it for his Health Care Inc. newsletter, so with his blessing, I’m going to cut-and-paste some of that here. Enjoy.

Continue to STAT+ to read the full story…

STAT+: America’s employer health insurance is decaying

This is the online version of STAT’s weekly email newsletter Health Care Inc. Sign up here.

Hello to all friends, new and old. We are officially launching a series called Out of Pocket, Out of Reach, which explores the different ways the employer-based health insurance system is crumbling. I want to hear from you: how your job-based coverage is affecting you or your business, whether you love it or hate it, and everything in between. Don’t be shy: bob.herman@statnews.com.

U.S. workers and businesses are getting soaked

There’s a very high likelihood that you, dear reader, get your health insurance from your job or the job of a loved one. There’s also a very high likelihood your earnings have suffered over time, quietly behind the scenes. It’s arguably never been worse than now, and it isn’t likely to get better.

Continue to STAT+ to read the full story…

AI Tackles Tuberculosis, Identifies Drugs that Penetrate Bacteria Membrane

According to the World Health Organization (WHO), tuberculosis, caused by the bacterium Mycobacterium tuberculosis (Mtb), is the world’s deadliest single-agent caused infection, responsible for 1.23 million deaths in 2024. The bacterium’s outer cell membrane is difficult hard to penetrate, making few drugs effective in treating the disease.   

In a new study published in Nature Microbiology titled, “Identification of chemical features for improved outer membrane permeation in mycobacteria using machine learning,” researchers from University of Massachusetts (UMass) Amherst have developed new methods to measure which chemical compounds can cross the outer bacterial membrane. 

“Mtb is unique,” said Sloan Siegrist, PhD, associate professor of microbiology at UMass Amherst. “Not only does it have two membranes that protect the cell from antimicrobial chemical compounds that we might use to kill it, its outer membrane is unlike any other biological barrier out there.” 

Siegrist’s lab specializes in finding vulnerabilities in the mycomembrane to develop drugs that can effectively treat tuberculosis. However, traditional drug discovery has relied on low throughput experimental screens. In 2023, Siegrist, in collaboration with Marcos Pires, PhD, professor of chemistry at the University of Virginia, published Peptidoglycan Accessibility Click-Mediated AssessmeNt (PAC-MAN), a method that can test many compounds in parallel. 

“Marcos and I wanted to harness measurements of known chemicals to predict compound uptake for unknown chemicals, so we brought in computational biologists and chemists, including my colleague Anna Green, PhD, from UMass Amherst’s Manning College of Information and Computer Sciences,” said Siegrist. 

Green uses computation to understand patterns in biological compounds. “Small molecules can be particularly difficult to analyze computationally,” she says. “Because they come in all different sizes with a wide range of molecular connections, you can’t describe them with a single measurement, by weight, say, or size.” 

Green and colleagues designed a machine learning model, the Mycobacterial Permeability neural Network (MycoPermeNet), trained on the PAC-MAN screening data. The model can predict how readily a compound permeates the mycomembrane from its chemical structure alone and points to the physical properties that help a compound penetrate Mtb’s defenses. 

“The mycomembrane lets some molecules through and keeps others out,” says Green. “There must be something about this membrane, and about the chemistry of each molecule, that decides which ones get in—and our combined tools help us figure out which ones can get through, and why.” 

The post AI Tackles Tuberculosis, Identifies Drugs that Penetrate Bacteria Membrane appeared first on GEN – Genetic Engineering and Biotechnology News.

The Download: your stake in OpenAI, and the Treasury’s AI warning

This is today’s edition of The Download, our weekday newsletter that provides a daily dose of what’s going on in the world of technology.

Your family’s $300 stake in OpenAI

Sam Altman’s proposal that Americans should share in the wealth created by AI is back in the spotlight, with reports that he is discussing giving the US government a 5% stake in OpenAI. At the company’s current valuation, that stake would be worth roughly $320 per American household.

The idea is meant to address concerns that AI companies are benefiting from human-generated work without compensating creators, while also easing fears that AI will cause a collapse of the labor market by providing a safety net. 

The details, however, remain unclear. Indeed, the offer may be more powerful as a political narrative than as a policy plan.

Read the full story on what the dividend proposal reveals about the future of AI.

—James O’Donnell

This article is from The Algorithm, our weekly AI newsletter. Sign up to receive it in your inbox every Monday.

The must-reads

I’ve combed the internet to find you today’s most fun/important/scary/fascinating stories about technology.

 1 A leaked Treasury report compares the AI market to the dotcom bubble
 Which contradicts the administration’s public optimism about AI. (NOTUS)
+ Fears that the market is overinflated are growing. (Reuters $)
+ And AI profits are hiding bigger risks in earnings reports. (FT $)
+ What even is the AI bubble? (MIT Technology Review)

2 Samsung profits have jumped 1,800% on booming AI chip sales
It just reported its third consecutive record quarterly profit. (BBC)
+ But its shares slumped over fears that the AI boom will stall. (Reuters $)
+ That boom has turned Samsung into a $1 trillion company. (CNBC)
 
3 A US cyber agency is using Mythos to audit government code
Sources say CISA is tapping Anthropic’s model to search for bugs. (Reuters $)
+ Agencies are using it despite Anthropic’s feud with the White House. (Axios)
 
4 Illinois’ governor has signed the nation’s strongest frontier AI law
It’s designed to protect citizens from AI risks. (Gizmodo)
+ US lawmakers are clashing over AI rules. (MIT Technology Review)
 
5 A hidden tracker in Claude Code has been exposed and removed
It secretly monitored users in China. (WP $)
+ Critics said it shows Anthropic’s willingness to surveil users. (Ars Technica)
+ The company has also found a hidden “thinking” space in Claude. (Axios)

6 Russia is suspected of flying drones over Europe from a shadow fleet
The flights were reportedly launched from commercial ships. (Ars Technica)
+ Europe has a drone-filled vision for future wars. (MIT Technology Review)
 
7 A controversial AI “actor” is set to star in its first feature film
Tilly Norwood will debut in a comedy-drama called “Misaligned.” (Variety)
+ A major actors union has lambasted the AI creation. (NBC News)

8 AI costs are driving US companies toward Chinese models
Businesses are hunting for cheaper model alternatives. (CNBC)
+ Chinese AI labs are betting big on open source. (MIT Technology Review)
 
9 Researchers have shown quantum proofs can beat classical ones
They found a problem that classical proofs can’t solve. (Quanta)

10 Earth will never be swallowed by the sun, according to new models
But it probably won’t be much fun to live here by that point anyway! (Wired $)

Quote of the day

“The goal might be to make machines in our image. But what I fear is that—perhaps without even quite noticing—we remake ourselves in theirs.” 

—Reporter Sarah O’Connor sounds a note of caution in her new book, We Are Not Machines, the Guardian reports.

One More Thing

mammoth walking on a strand of DNA

KATE DEHLER


Adventures in the genetic time machine

Eske Willerslev, a specialist in recovering DNA from old bones and objects, has made numerous breakthroughs. These include recovering the first more or less complete genome of an ancient human and 2.4-million-year-old genetic material from Greenland, revealing that today’s Arctic desert was once a forest with poplar, birch, and mastodons.

These findings are part of a wave of discoveries from what’s being called an “ancient-DNA revolution.” 

Beyond revealing stories of human migration and vanished ecosystems, scientists believe ancient DNA can unearth clues about modern diseases. It could even lead to a better food supply for our warming world. “And can we get that?” Willerslev asks. “Yes, I believe we can.”

Discover how ancient DNA could rescue the future

—Antonio Regalado

We can still have nice things

A place for comfort, fun, and distraction to brighten up your day. (Got any ideas? Drop me a line.)

+ Underworld’s electric set from EDC Las Vegas 2026 has been released as a full concert video.
+ This photographic journey through global soccer culture captures the mad passion of fandom around the world.
+ Feeling unhinged? Me too. This playlist of gloriously intense classical music sympathetically captures the mood.
+ If you’re looking for visual inspiration, this collection of graphic design archives from across the web is a goldmine.

Why worms (and microbes) are catching on as a manure pollution solution

Anthony Agueda, a third-generation California dairy farmer, pulls a rake through a bed of dark, wet wood chips on his family’s land in Hickman, a tiny town in the state’s agricultural heartland.

He reaches down with both hands and pulls up a clump of muck, turning it over to reveal a half-dozen squirming red earthworms. There are likely hundreds of thousands more wriggling just under the surface of the three-foot mound of wood and crushed river rock before us, which stretches across the equivalent of six football fields. These natural materials form a biofilter that may dramatically cut the methane, nitrous oxide, and water pollution generated by the massive amounts of manure that hundreds of Holstein cows produce each day.

Agueda’s family business, the Alberto Dairy, was one of the first cattle operations in California to adopt this approach to manure treatment, developed and patented by the Chilean company BioFiltro. Eight more of these so-called vermifiltration systems are already operating on US dairies, according to the company, while another 16 are under construction or set to be next year, nearly all of them in California. 

Vermifiltration is just one of a variety of methods that farmers, companies, and scientists are employing to drive down manure pollution as the livestock industry faces growing pressure to address the environmental harms from one of the smelliest parts of the business. California, easily the nation’s largest milk producer, has established a handful of programs to promote their adoption, including one initiative that has funneled more than a billion dollars to farms.

Researchers stress that much more work needs to be done to determine the most effective approaches, the trade-offs between them, and their success over the long term, under actual farm conditions.

Agueda says that he and his family recognized the need to adopt new practices as environmental rules tightened. They were drawn to vermifiltration because it’s simple and relatively cheap compared with other, higher-tech options.

“California daily farmers are constantly facing more and more regulation,” says Agueda, standing alongside one of the farm’s free-stall barns. “This makes me excited, because it shows how we are part of the solution.”

The growing manure problem

Manure is responsible for a significant portion of the climate pollution from livestock operations. The World Resources Institute estimates that manure management on dairy and swine farms accounts for 1.6% of the US’s greenhouse-gas emissions. Globally, manure storage and processing makes up about 10% of the livestock industry’s contributions to climate change. 

“Farms have become larger in the past two decades or so, so there’s much more manure—and that has to be stored somewhere,” says Swati Hegde, the organization’s global manager of agricultural methane.

Typically, cattle and swine farms spray manure into lagoons or tanks, creating a foul-smelling, low-oxygen slurry in which microorganisms known as methanogens thrive. They gobble up hydrogen, carbon dioxide, and other compounds and produce methane as a by-product. Other microbes in the mix produce smaller amounts of nitrous oxide.

A pair of Holstein cows poke their heads through the rails of a free-stall barn at the Alberto Dairy.
JOE PROUDMAN/UC DAVIS

Both are particularly potent greenhouse gases, with as much as 30 to nearly 275 times the warming power of carbon dioxide, respectively, over a century.

The slurry is often spread onto fields to add nutrients to the soil. When it’s done excessively or improperly, this part of the practice can pollute soil or groundwater with drug residues, pathogens like salmonella and E. coli, and nitrates. Nitrates that leach into drinking water have been linked to a variety of human health risks. And those that flow into rivers, lakes, and coastal waters can spawn algae blooms that poison fish, block sunlight, suck up oxygen, or form large coastal dead zones devoid of marine life.

Policy drivers

A number of regions, nations, and states have passed regulations or offered subsidies designed to limit the pollution from livestock manure, but so far, most of the major initiatives have focused on water contamination rather than greenhouse-gas emissions.

The European Union, for instance, restricts the amount of manure that farmers can apply to fields and requires member nations to monitor nitrate levels in ground and surface water. The US’s Clean Water Act requires large livestock operations to obtain permits and develop manure management plans that limit pollution. 

But California has arguably done the most to use government policy specifically to drive down the methane emissions from livestock. The dairy industry accounts for about 45% of the state’s pollution from the potent greenhouse gas, and more than half of that comes from manure, according to the government’s estimates. 

In 2016, the state enacted a law that requires dairies, landfills, and other businesses to cut methane emissions 40% below 2013 levels by 2030, as part of a broader effort to reduce pollution from powerful but short-lived greenhouse gases. The measure directed the California Air Resources Board, the state’s main climate regulatory agency, to set up various incentive programs to encourage these industries to shift to cleaner practices. 

“In terms of bang for your buck, short-term benefits, methane can go a long way toward reaching climate goals,” says Tawny Mata, director of California’s Office of Agricultural Resilience and Sustainability. 

Between these various programs—and falling livestock numbers in the state—the dairy sector is on track to reduce annual methane emissions by the equivalent of 5 million metric tons of carbon dioxide by 2030, the state estimates. That would still fall about 4 million tons short of the target under the 2016 law.

The downsides of dairy digesters

Excluding the decline in herd populations—which has been driven by growing international competition and rising costs—the vast majority of California’s estimated methane reductions come from the use of what are known as anaerobic digesters. This technology entails covering the slurry lagoons to prevent methane from leaking into the air and then piping the biogas into separate vessels, where it’s cleaned and converted into natural gas. 

Under California’s Low Carbon Fuel Standard program, dairies that use digesters to produce gas delivered into pipelines can earn credits and sell them to petroleum refineries and other major polluters, as a means of helping those companies meet their own emissions reduction requirements. 

The gas can then fuel power plants, produce hydrogen, or power natural-gas vehicles. These uses still release carbon dioxide, but the state considers it a climate win because it avoids the release of methane, which traps even more heat. 

The rich revenue stream from California’s program has spurred hundreds of US farms to install anaerobic digesters over the last decade. Since 2020, it has produced more than $1 billion for farms, Cal Poly researchers noted in a paper last year.

But there are a variety of concerns about this approach.

The first is that it’s viable only for farms with about 2,000 cattle or more, because the equipment is very expensive to install, says Frank Mitloehner, a professor and chair of the Department of Animal Science at the University of California, Davis.

“For the lion’s share of dairies, digesters will not be a solution,” he says. 

Since the manure is often still spread across fields, digesters also do little to address the water pollution problems—and can even exacerbate them because of some of the chemistry that occurs during that process. 

Yet the huge subsidies flowing to digesters have steered money, energy, and attention away from other solutions that may offer better overall environmental outcomes, says Danny Cullenward, a senior fellow with the Kleinman Center for Energy Policy at the University of Pennsylvania, who has closely studied the California program.

“That is really not a solution at scale, and it’s diverting a huge fraction of precious resources to what I think is mostly not the right answer,” he says. 

Alternatives

The high up-front costs and limitations of digesters have spawned growing interest in alternative solutions—many of which work by reducing the formation of methane in the first place instead of turning that methane into a sellable fuel.

One of the cheapest, easiest, and most popular approaches, known as solid separation, uses simple machinery like a screw press to squeeze much of the water out of the manure slurry. The remaining solids are dry and exposed to open air, shifting away from the oxygen-free conditions in which methane is readily produced.

Other methods include increasing acidity in lagoons, bubbling air through them, or adding methane-eating microbes to the slurry, all of which alter the chemistry in ways that promise to reduce the amount of methane released. One company, Sedron Technologies of Sedro-Woolley, Washington, has also developed a sort of high-tech solid separation approach that extracts several marketable products from the animal waste, including a liquid organic fertilizer.  

The state of California set up a pair of additional programs to help smaller farmers adopt some of these other approaches, dubbed the Alternative Manure Management Program and the Dairy Plus Program.

The bulk of the funds have gone to solid separation systems. But the state has provided more than $18 million to support 15 vermifiltration projects. The Alberto Dairy has received nearly $2 million between the two programs.

Oreo cows

As I drove down a dusty road bordering the dairy, black-and-white bovines, affectionately known as Oreo cows, stretched their heads through the rails of an open barn, nibbling on golden silage scattered along the structure. Agueda’s grandfather Antonio Alberto founded the dairy 45 years ago in nearby Atwater, California, but eventually settled in Hickman, population 604, in 1989. 

A series of large metal contraptions separate most of the solids from the manure wastewater.
JOE PROUDMAN/UC DAVIS

It was mid-March but already above 80 °F in the Central Valley, which is walled off from the cool Pacific air by the coastal mountain range. Knee-high oat stalks swayed in fields that stretched to a line of almond trees in the distance.

Agueda, who graduated from Fresno State last year and now helps lead the operations on the farm, met me and UC Davis’s Mitloehner, who has studied the effects of vermifiltration, along the side of the barn. (UC Davis has no affiliation with the farm, but the university helped facilitate the meeting.)

He led us along dirt lanes as he explained the workings of the vermifiltration system, which they began using in October 2024.  

As before, a flush system washes manure from the floors of the barns into a large collection pit. But now a set of pumps funnels it through a series of large V-shaped metal contraptions standing on a nearby concrete pad, where mechanical screens separate most of the solids from the water.

A conveyor belt takes away the solids, which the farm composts for cow bedding or fertilizer. The remaining liquid moves through a system of pipes, first to settling ponds and then on to an irrigation system suspended above the vermifiltration beds. The long, tubular structure runs over the mounds on wheels set in gravel tracks, wetting the wood chips as it goes. The worms and various microbes residing in the biofilter then set to work consuming much of the remaining solid material, according to BioFiltro.

An irrigation system sprinkles wastewater onto the vermifiltration beds.
JOE PROUDMAN/UC DAVIS

“Once the water is sprinkled on top, it takes about four hours from beginning to end for it to percolate through and drain to the end,” Agueda says.

He then defers to Mitloehner to explain the science of what happens as it does, adding, “I’m just the dairyman.”

The science

Mitloehner says he was skeptical of BioFiltro’s claims when he first heard them, particularly the assertion that the system could nearly eliminate nitrogen and, with it, the various forms of pollution it can produce, including ammonia and nitrates. 

So he decided to study a similar setup at the Fanelli Dairy, an operation in Hilmar, California, about 20 miles to the south. He and colleagues monitored the emissions from wastewater samples that were taken from the system before and after the liquid moved through the filter. In a paper published in 2018, the researchers concluded that vermifiltration reduced ammonia emissions from the resulting water by about 90%.

BioFiltro, whose tagline is “worm-powered solutions,” states that its technology “catalyzes the digestive power of worms and microbes to remove up to 99% of wastewater contaminants.”

But Mitloehner questions how big a role the invertebrates play in the process, calling it “kind of a catchy narrative.”

His take is simpler: The rocks and wood chips form a porous filter that replaces the anaerobic environment of a manure lagoon with an aerobic one. And in that oxygen-rich environment, different types of microbes thrive. 

His study suggests that these microbes are highly effective at converting nitrogen compounds in manure into nitrogen gas—a benign gas that makes up 78% of Earth’s atmosphere—instead of ammonia. That’s notable because while ammonia in manure acts as a fertilizer when it’s applied to fields, it also converts into the nitrates that can leach into groundwater.

Several more recent studies, which were partially or fully funded by BioFiltro and one of its regional distribution partners, Organix, produced similarly promising results. For instance, a 2022 study in Bioresource Technology Reports, also conducted at the Fanelli Dairy, concluded that the filter removed nearly 85% of the nitrogen in the operation’s wastewater. 

But a befuddling wrinkle is that when it came to methane, those studies and Mitloehner’s independent one found nearly opposite results.

While both the company- and partner-supported studies concluded that the filter eliminated the vast majority of methane pollution, Mitloehner’s study found that methane emissions were nearly 85% higher than those from the lagoon. 

In a follow-up email exchange, Mitloehner stressed that it’s not appropriate to compare his results with those that emerged from the other study at the same dairy, because the teams used very different methods, instruments, and measurement periods. Moreover, the focus of his research was the effect on nitrogen.

""
Anthony Agueda pulls a rake through a vermifiltration bed at his family’s dairy.
JOE PROUDMAN/UC DAVIS

He said it’s “entirely reasonable” and “biologically plausible” that vermifiltration could substantially reduce methane emissions, simply by creating that aerobic environment.

“That said, I would be cautious about calling the magnitude of the reduction a fully settled issue,” he added. “While the available studies, including those you mentioned, point in the same general direction, the number of independent studies remains relatively limited, and results can vary.”

Patrick Beckett, BioFiltro’s vice president of quality and R&D, also stressed that there were crucial differences in the methodology of Mitloehner’s study that could have affected his methane findings.

In addition, he said the Organix funding came by way of a Washington state grant and described that study and the one BioFiltro supported as “high quality, peer reviewed” research that “has been submitted to other technical third parties for review and acceptance.”

Beckett says he agrees that additional independent reviews of BioFiltro’s systems is “fair and necessary” and notes that other studies have occurred or are underway.  

“That said,” Beckett wrote in an emailed response to questions from MIT Technology Review, “it seems unreasonable that BioFiltro would be held to a standard of not being allowed to invest in technical research by qualified third parties to learn more about the capabilities of our technology, and use the results of that research to enter new markets and to understand the value we can bring to projects or entire industries beyond water treatment.”

Milk money

BioFiltro is already building a business model around the available findings.

The company, founded in 2009, has been selling its vermifiltration systems or services to other industries around the world for years. It says there are around 225 operating in nine countries, at sites including municipal wastewater facilities, wineries, fruit processors, and other industrial operations.

But BioFiltro, whose US headquarters are in Davis, California, is seeing increasing demand among dairies as the industry faces growing pressure to address manure pollution. Late last year, it raised $35 million that the business says it will use, in large part, to accelerate its growth across the sector.

In an interview, Sarah Ploss, the company’s senior vice president of agriculture, explains the basic financial template for how it works with dairies: BioFiltro pays for, owns, installs, and operates the system. The farm, in turn, covers a share of the additional electricity, operations, and maintenance costs. 

Ploss says the dairy gets back clean water and the ability to focus on what it does best: producing milk. For its part, BioFiltro can generate carbon credits from the reduction in greenhouse gases, which it can then sell to makers of consumer packaged goods that are looking for ways to address the emissions throughout their supply chains, she says.

BioFiltro says that Verra, which sets standards for and assesses greenhouse-gas crediting projects, has registered two of its projects: the Royal Dairy and Moxee Dairy, both in Washington.

The Swiss confectionary giant Nestlé has bought more than 150,000 credits generated by the Royal Dairy’s vermifiltration system, according to an offsets database managed by CarbonPlan, which assesses the scientific integrity of climate action programs. Ploss said that BioFiltro has sold more than 200,000 credits from the project so far, and adds that it secured a different buyer for a project in California, which she said she couldn’t name. 

The vermifiltration system has cleaned up the water that circulates through various parts of the Alberto Dairy operation.
JOE PROUDMAN/UC DAVIS

Three additional projects involving BioFiltro systems took the initial steps to become registered through Verra but didn’t move forward and weren’t built, Ploss said in an email. The request for registration for the Alberto Dairy estimates that the system there will reduce emissions by the equivalent of more than 30,000 metric tons of carbon dioxide per year. 

BioFiltro could take advantage of another revenue source as well: selling what it calls vermicompost, a rich soil additive composed of the leftover materials in the biofilter, including worm castings—a combination of cocoons, excrement, and remains. At retail, worm castings can run more than $500 per ton.

Beckett says the company is still developing that market but notes that it could help the industry offset rising fertilizer costs. 

“I think we’re going to enable a larger-scale use and adoption of it that could be meaningful to agriculture,” he says, adding: “These will become basically soil production facilities.” 

Concerns

Determining how well vermifiltration and other manure management approaches work will require more time and more research, experts say. 

Katharine Dickson, an agricultural emissions scientist who recently finished a postdoctoral program at UC Davis, says there should be in-the-field accounting to ensure that any of these methods are working as well as hoped—or to the degree government policy programs assume. All of which is tricky to achieve given the dynamic biological processes playing out in live animals and microbial communities on open farms, she adds.

“Vermifiltration, for example, depends on a live earthworm population whose performance is sensitive to temperature, moisture, and toxicity, and can shift with seasonal conditions or changes in herd size and manure characteristics on a given farm,” Dickson said in an email. 

The use of carbon credits to earn money from vermifiltration projects raises a different set of potential concerns. Most notably, if the methane decreases aren’t as significant as assumed, the projects could receive more credits than they deserve. 

There are more complicated issues as well. For the carbon credit system to make any real difference in the net amount of greenhouse gas in the atmosphere, it must produce emissions reductions that wouldn’t have occurred without that financial incentive. If it was going to happen anyway—as a result, say, of rich grants, legal pressures, or looming policies—the buyer of the credits can’t legitimately claim to have made any progress on its own climate emissions, says Grayson Badgley, a research scientist at CarbonPlan.

On that point, if California agriculture doesn’t meet its looming methane reduction targets, the carrots the state offers could be replaced by sticks: The California Air Resources Board recently began discussing rules that would force, rather than nudge, the sector to meet the 40% reduction required under the 2016 law.

“If lots of dairies are cleaning up their act ahead of pending regulation, it really does seem like the regulation, not offsets, is driving that action,” Badgley wrote in an email. “Trying to collect as many offsets prior to that deadline might adhere to the rules of the market, while still raising questions about whether those rules have enabled real climate action.”

Investing in sustainability 

Beckett disagreed that the possibility of forthcoming regulations undermines the case for generating carbon credits from current projects. 

“It’s true the state has net reduction targets that it hopes to meet, but it’s clear the state of California has favored market-based solutions and tried to provide some support via grant programs,” he wrote. “I’m on the science side of our business, not the business development side, but still think I can tell you with complete transparency that we would not have systems installed on [California] dairies without the sale of voluntary carbon credits.”

Ploss also stressed that the company goes through a careful “validation and verification process” on the farms to understand how much vermifiltration reduces greenhouse gases.

“We’ve got sensors and cameras and all sorts of stuff so that we can look into any of our systems, 24-7,” Ploss says. “We know through sampling. We know through what’s going through the system, what came out of the system. We know by all the measurements on any given month: What did that system do in terms of generating carbon credits?”

Agueda also disputes the critique. 

“The installation of the vermifiltration system would not have occurred without the ability to generate carbon credits,” he said in an email. “The project required a substantial capital investment, and the anticipated carbon credit revenue was a key factor in making the investment financially feasible.”

Anthony Agueda helps to lead the operations at the Alberto Dairy.
JOE PROUDMAN/UC DAVIS

California decided to incentivize vermifiltration, along with other approaches, because it can offer multiple benefits, including cleaner water, less nitrogen, and lower greenhouse-gas emissions, while also creating economic value from manure, wrote Roberta Franco, a senior environmental scientist at the California Department of Food and Agriculture, in an emailed response to questions from MIT Technology Review.

She added that the decision was based on a number of studies as well as the 2022 recommendations from a task force composed of scientists, technical experts, and others. 

Even if California has made missteps, most notably in funneling too much money to anaerobic digesters at the expense of other methods, it’s created a test lab that’s achieved real progress and provided lessons that other regions can learn from.

One way or another, more parts of the world will need to set up similar programs, offering greater support or creating stricter rules, if we hope to really drive down the emissions from manure, says Maria Bowman, who leads the Agricultural Nitrogen Transformation Program at Spark Climate, a San Francisco nonprofit.

For his part, Agueda says that the vermifiltration system has offered a number of benefits to his family’s farm, at little additional cost to them. By cleaning up the water that cycles back through their flush and irrigation systems, the biofilter has reduced clogging, decreased odors, and improved the health of the herd.  

He says that each generation modernizes dairy farming in its own way. His father and uncle, for instance, incorporated computers and data management systems into the daily operations of the Alberto Dairy. He believes it’s the responsibility of his generation to make a similar effort to reduce the pollution that’s long plagued the sector.

“We knew that in the next generation we have to invest in environmental sustainability,” he says. “We didn’t know if it was gonna work or not, but we’re very happy with how it’s turned out.”

STAT+: America’s small businesses are giving up on health insurance

It has never been more difficult for employers to offer health insurance for their workers. That’s especially true for America’s small businesses, the backbones of entire communities. More and more, they’re giving up entirely.

America’s employer-based health insurance system — the dominant form of coverage for people younger than 65 — is crumbling. The percentage of working-age adults who get their health coverage from a job has declined from 67% in 1998 to about 60%. It’s also more expensive than ever. STAT interviewed dozens of people across the country as part of a series that probes how and why this is happening. Panic, despair, and anger are most apparent among smaller shops and firms.

Small business owners and workers feel as though most, if not all, of their options are unaffordable, especially if they have plans with high out-of-pocket costs. Rising premiums — driven by high prices for hospitals, doctors, and prescription drugs and more intensive care — are eating into bottom lines and paychecks. Desperate companies are getting rid of traditional health benefits at an unprecedented pace. This shift is fraying the uniquely American expectation that jobs come with protection for injuries and illnesses — an expectation that is the product of World War II wage controls, industry opposition to government health care, and the biggest break in the tax code. 

Continue to STAT+ to read the full story…

5 takeaways from STAT’s series on the soaring cost of health insurance

More than 150 million Americans get their health insurance from a job, making it the primary way people in the U.S. get coverage. STAT is examining this crucial source of insurance to understand how and why it is becoming unaffordable for workers and their families across the country.

Health benefits are fading away at small companies

Nearly all large companies offer health insurance. But fewer than 60% of smaller firms, with 200 or fewer workers, now offer insurance, an all-time low. The costs of health insurance are pushing small businesses — beloved by politicians and the bedrocks of entire communities — to a financial cliff. Watering down their insurance plans, or deciding not to offer insurance at all, makes it more difficult for these businesses to retain employees.

Read the rest…

Obamacare rolls shrank dramatically in many states over the past year, new federal data shows

NEW YORK — States across the country saw steep drops in the number of people covered by the Affordable Care Act over the past year, with Ohio and Oklahoma each losing nearly one-third of enrollees, according to new federal data that provides the first complete 50-state breakdown of sharp enrollment declines following the January expiration of enhanced subsidies.

The data, posted in late June by the Trump administration and first reported on by The Associated Press, reveals how changes in each state’s insured population led to around 2.6 million fewer Americans having Obamacare plans in February compared with the same time last year.

Read the rest…

Structural Biology Reveals New Drug Targets for Rare Neuromuscular Disease

Researchers at the University of California San Diego have uncovered the structural mechanisms that cause congenital myasthenic syndromes (CMS), revealing mutation-specific treatment strategies and identifying an existing antidepressant as a promising candidate for drug repurposing.

The study, published in Nature, explains how disease-causing mutations alter the human acetylcholine receptor (AChR), the protein responsible for converting nerve signals into muscle contraction. The findings also provide a framework for developing precision medicines tailored to the specific mutation carried by individual patients.

CMS is a rare inherited group of neuromuscular disorders that typically appears at birth or early childhood. Mutations in the AChR impair communication between nerves and muscles, leading to muscle weakness, difficulty walking, breathing problems, and, in severe cases, paralysis or death. Although more than 50 disease-causing mutations have been identified, the molecular mechanisms underlying these disorders have remained largely unknown.

To address this question, the investigators determined 12 high-resolution structures of representative mutant AChRs with and without therapeutic compounds. By combining these structural data with functional studies, they identified common mechanisms that explain the two major forms of CMS.

Fast-channel CMS is caused by loss-of-function mutations that reduce receptor opening and weaken neuromuscular transmission. The researchers discovered a previously unknown allosteric binding pocket that can be targeted by positive allosteric modulators (PAMs), compounds that enhance receptor activity without directly activating the channel.

Notably, different PAMs restored receptor function in different patient mutations rather than producing a universal effect. The authors write that this “mutation-specific activity underscores the capability and necessity of tailoring therapies to individual patient genotypes.”

The study also showed that the newly identified drug-binding pocket is largely absent until a PAM binds, creating an opportunity to design more effective compounds that stabilize receptor function. The authors conclude that these findings point to “a new class of allosteric drugs” with potential applications not only in fast-channel CMS but also in disorders such as myasthenia gravis, in which acetylcholine receptor function is compromised.

The team also investigated slow-channel CMS, a gain-of-function disorder in which receptors remain open too long, causing excessive calcium influx and progressive damage at the neuromuscular junction.

Structural analyses revealed that the current therapies quinidine and fluoxetine act through a shared mechanism, blocking the receptor pore despite their distinct chemical structures.

The investigators also evaluated reboxetine, an antidepressant already approved in several countries. Unlike the existing drugs, reboxetine selectively inhibited abnormal receptor activity across multiple slow-channel mutations while largely sparing normal receptor function.

The authors believe that reboxetine’s ability to suppress pathological receptor activity, together with its established clinical safety profile, “positions it as a potential candidate for slow-channel CMS therapy,” although they caution that its known adverse effects warrant careful evaluation in future clinical studies.

Beyond identifying therapeutic opportunities, the study establishes unifying principles of CMS pathogenesis. The researchers found that fast-channel mutations weaken the coupling between acetylcholine binding and channel opening, whereas slow-channel mutations stabilize an abnormally widened, desensitized-like pore. These shared structural mechanisms explain why genetically diverse mutations produce similar clinical symptoms while requiring different therapeutic strategies.

The work also revises understanding of receptor biology. The authors write that their findings “overturn the traditional view of the β subunit as merely a structural scaffold,” instead demonstrating that it plays “a central role in the gating cycle.”

Overall, the researchers conclude that their integrated structural and functional analyses define how CMS mutations disrupt receptor gating, reveal the molecular basis of current and candidate therapies, and identify new druggable sites for intervention. They conclude that the work provides “a roadmap towards the development of safer and more effective, mutation-specific treatments for both fast-channel and slow-channel CMS.”

 

 

The post Structural Biology Reveals New Drug Targets for Rare Neuromuscular Disease appeared first on Inside Precision Medicine.